Objective: Preoperative anemia is associated with increased morbidity and mortality after surgical operations. The purpose of this study was to examine the impact of preoperative anemia on outcomes among patients with peripheral arterial disease who have undergone open lower extremity bypass.
Methods: The American College of Surgeons National Surgical Quality Improvement Program database for year 2013 was used for this analysis. Patients were organized into three groups based on hemoglobin level: severe anemia (<10 g/dL), mild anemia (10-12 g/dL for women and 10-13 g/dL for men), and no anemia (>12 g/dL). Bivariable analysis was performed for preoperative, intraoperative, and postoperative risk factors among patients with anemia. Multivariable analysis was used to determine risk factors associated with mortality and limb loss.
Results: A total of 2381 patients (31.9% women, 68.1% men) were identified in the National Surgical Quality Improvement Program database who underwent lower extremity bypass in the year 2013. Among these patients, 328 (14.0%) had severe anemia, 898 (38.3%) had mild anemia, and 1120 (47.7%) did not have anemia. Patients with severe anemia were more likely to have a history of hypertension, diabetes, dialysis dependence, congestive heart failure, cancer, preoperative transfusion, and critical limb ischemia presenting as tissue loss (P < .05). They were also more likely to have a hospital stay >7 days, cardiac arrest requiring cardiopulmonary resuscitation, postoperative acute renal failure, return to the operating room, unplanned reoperation related to lower extremity bypass, and bleeding requiring transfusion (P < .05). On multivariable analysis, the following factors were found to have a significant association with mortality: dialysis (odds ratio [OR], 4.1; confidence interval [CI], 0.5-2.2; P < .05), myocardial infarction or stroke (OR, 9.4; CI, 1.3-5.3; P < .05), and length of hospital stay >7 days (OR, 1.9; CI, 1.3-5.3; P < .05). The following factors had strong association with limb loss: dialysis (OR, 1.9; CI, 1.0-3.5; P < .05), myocardial infarction or stroke (OR, 1.7; CI, 1.1-2.8; P < .05), and hospital stay >7 days (OR, 7.1; CI, 3.9-13.3; P < .05). Neither mild nor severe anemia was found to be a significant factor for death and amputation on multivariable analysis.
Conclusions: This study does not show any significant correlation between anemia and mortality or limb loss, suggesting the importance of other factors instead. Objective: Previous studies comparing endovascular revascularization (ENDO) and surgical bypasses (OPEN) for lower extremity arterial occlusive disease often do not differentiate outcomes for femoral/popliteal and infrapopliteal diseases. In this study, we investigate the 30-day outcomes/limb salvage of OPEN vs ENDO in patients with critical limb ischemia (CLI) in each disease category: superficial femoral/popliteal (SFA/POP) or infrapopliteal occlusive disease.
Methods: Patients who underwent interventions for CLI were identified in the targeted American College of Surgeons National Surgical Quality Improvement Program database from 2011 to 2015. They were first stratified by type of intervention (OPEN vs ENDO), then by indication (rest pain and tissue loss) and anatomic interventions (SFA/POP and infrapopliteal). The 30-day outcomes, especially amputation rate, were compared between ENDO and OPEN in each anatomic distribution for rest pain or tissue loss. Multivariate regression was performed for analysis.
Results: There were 10,624 patients revascularized for CLI: 3938 received ENDO and 6686 underwent OPEN. ENDO patients were more likely to have end-stage renal disease, congestive heart failure, hypertension, and diabetes. OPEN patients were more likely to smoke, to have chronic obstructive pulmonary disease, and to have American Society of Anesthesiologists score 4 or 5. There was no statistically significant difference in 30-day mortality (2.4% vs 2.7%; P ¼ .3) between OPEN and ENDO across all groups. ENDO was associated with fewer cardiac, pulmonary, and wound complications but a higher rate of major amputations (5.3% vs 4.3%; P ¼ .018) within 30 days (Table) . Patients with tissue loss had a higher rate of amputation than did those with rest pain (5.4% vs 3.6%; P < .0001). Amputation rate in patients with rest pain was not influenced by anatomic location or type of intervention. However, further analysis in Table. The 30-day outcomes of surgical bypasses (OPEN) vs endovascular interventions (ENDO) in patients with critical limb ischemia (CLI) 
